Details for: TARO-LANSOPRAZOLE
Company: SUN PHARMA CANADA INC
| DIN | DIN name | Active Ingredient(s) | Strength | Dosage Form | Route of Administration |
|---|---|---|---|---|---|
| 02402610 | TARO-LANSOPRAZOLE | LANSOPRAZOLE | 15 MG | CAPSULE (DELAYED RELEASE) | ORAL |
| 02402629 | TARO-LANSOPRAZOLE | LANSOPRAZOLE | 30 MG | CAPSULE (DELAYED RELEASE) | ORAL |
Summary Reports
Summary Safety Review - Proton Pump Inhibitors - Assessing the Potential Risk of Clostridium difficile Infection
Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)]
Summary Safety Review - Proton Pump Inhibitors (PPIs) - Assessing the risk of a type of skin reaction [Subacute Cutaneous Lupus Erythematosus (SCLE)]
Consumer Information
The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.